Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Overview of Hematopoiesis

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Flow properties of single origin chocolates: Effect of product formulation and particle size.

Journal of food science·2024

Same author

A versatile laser-based apparatus for time-resolved ARPES with micro-scale spatial resolution.

The Review of scientific instruments·2024

Same author

The use of predator tags to explain reversal movement patterns in Atlantic salmon smolts (Salmo salar L.).

Journal of fish biology·2024

Same author

Author Correction: Optical manipulation of Rashba-split 2-dimensional electron gas.

Nature communications·2022

Same author

Optical manipulation of Rashba-split 2-dimensional electron gas.

Nature communications·2022

Same author

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto, Ont.)·2020

Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026

Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026

Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026

Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026

Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026

Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 30, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

How we mobilize haemopoietic stem cells.

K E Herbert¹, J-P Levesque, A K Mills

¹Division of Cancer Medicine, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, Victoria, Australia.

Internal Medicine Journal

|August 12, 2011

Summary

This summary is machine-generated.

Optimizing hematopoietic stem and progenitor cell (HSPC) collection is crucial for transplantation. Novel mobilization strategies are emerging, offering potential improvements in efficacy and safety for clinical practice.

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Related Experiment Videos

Last Updated: May 30, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Area of Science:

Hematology
Oncology
Cellular Therapy

Background:

Haemopoietic stem and progenitor cell (HSPC) mobilization is critical for stem cell transplantation.
Current methods face challenges in optimizing cell collection, apheresis efficiency, and minimizing toxicity.
Understanding molecular mobilization mechanisms is advancing therapeutic options.

Purpose of the Study:

To review recent advancements in HSPC mobilization strategies.
To evaluate the efficacy and safety of novel mobilization agents.
To propose a clinical algorithm for HSPC mobilization.

Main Methods:

Literature review of emerging HSPC mobilization strategies.
Analysis of clinical evidence regarding efficacy and safety of novel agents.
Development of a practical algorithm for clinical application.

Main Results:

Novel strategies show promise in improving HSPC mobilization.
Emerging data suggest favorable safety profiles for new agents.
A structured approach to mobilization can enhance collection success.

Conclusions:

New molecular insights are driving innovative HSPC mobilization techniques.
Clinicians need guidance on integrating novel strategies into practice.
The proposed algorithm aims to standardize and improve HSPC collection for transplantation.